quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:22·69d
SECFiling
Brainstorm Cell Therapeutics Inc. logo

Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

BCLI· Brainstorm Cell Therapeutics Inc.
Health Care
Original source

Companies

  • BCLI
    Brainstorm Cell Therapeutics Inc.
    Health Care

Related

  • SEC23d
    SEC Form 10-K filed by Brainstorm Cell Therapeutics Inc.
  • SEC23d
    Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR23d
    BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update
  • SEC55d
    Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
  • PR56d
    Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
  • PR62d
    Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
  • SEC104d
    Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
  • PR128d
    Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022